News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Join Flintloque Management systems to learn all about the new ground-breaking ISO 56001: Innovation Management System

Dr. Farid Khan, CEO of PharmaKure was awarded Asian Tech Pioneer in his work in Biotech.

A team of vision researchers from the University of Liverpool have received £2.1m to develop a contact lens that can repair eye damage.

PharmaKure has launched a study to examine the relationship between blood biomarkers and historical PET scans or CSF in patients with Mild Cognitive Impairment due to Alzheimer’s Disease.

In Silico trials offer great potential savings in time and money. However, they are not without challenges. Are you developing an In Silico model, or are in the process of using one or have...

Often, research projects or sample storage facilities will start small, using just one or two containers - often referred to as ‘Dewars’ - to store a few samples. As the facility grows, ...

Genomics has provided us with a new armoury for tackling pandemics, enabling us to respond faster and with more accuracy to COVID-19.

With over 900 students from 20 institutions and about 40 companies presenting, read about the recent Bionow Digital Careers Fair

As the world enters a new wave of lockdowns, Biorelate, a Manchester-based AI start up, extends its free use of Galactic to all researchers.

Stream Bio and MIP Diagnostics have joined forces to develop a SARS-CoV-2 (Covid-19) detection reagent, a lateral flow point of care rapid diagnostic and an ELISA type assay for high throu...

OPENCORONA consortium awarded €3million funding by Horizon 2020 to support emergency research and development against the COVID-19 outbreak

The impact of the latest generation of drugs for the healthcare industry

Our Valued Sponsors & Partners